PERSONALIZED MEDICINE COALITION

Health Issues

Congressional Personalized Medicine Caucus S. 832/H.R. 1492 the Ensuring Pathways to Innovative Cures Act H.R. 946 Optimizing Research Progress Hope and New Cures Act H.R. 1672 Maintaining Investments in New Innovation Act House Energy and Commerce Committee Privacy Working Group Request for Information CMS Implementation of Medicare Drug Price Negotiation Program/ Medicare Drug Price Negotiation Program; Draft Guidance for the Medicare Drug Price Negotiation Program: Implementation of Sections 1191 - 1198 of the Social Security Act for Initial Price Applicability Year 2028 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026, 2027, and 2028 Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2026 Rates; Requirements for Quality Programs; and Other Policy Changes (CMS-1833-P) Office of Science and Technology Policy Request for Information on the Development of an Artificial Intelligence (AI) Action Plan Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations [FDA-2024-D-4488] Considerations for the Use of Artificial Intelligence to Support Regulatory Decision Making for Drug and Biological Products [FDA-2024-D-4689] Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community

TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Science & Technology Policy (OSTP) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)

Budget/Appropriations

FY 2026 Food and Drug Administration Budget Priorities for CDER, CBER and CDRH FY 2026 National Institutes of Health Budget Priorities